by IHS | May 8, 2022 | Uncategorized
CHESTER, N.Y. (August 26, 2021) – Innovative Health Sciences, LLC (“IHS” or the “Company”) management announced today that IHS has received FDA clearance for its Insignis™ Subcutaneous Needle Sets. This regulatory clearance allows IHS to sell and distribute its...
by IHS | Mar 15, 2022 | Ukraine
CHESTER, N.Y.–(BUSINESS WIRE)–Andrew Sealfon, Chairman and Founder of Innovative Health Sciences LLC (“IHS”), today pledged 1,000 of his company’s unique portable non-electric IV pumps to victims of the Ukraine conflict. The Insignis™ Syringe Infusion...
by IHS | Nov 12, 2021 | Uncategorized
CHESTER, N.Y. (November 12, 2021) Innovative Health Sciences, LLC (“IHS” or the “Company”) will be presenting its breakthrough versatile and low cost non-electric infusion system at Medica, a world-renowned trade fair for medical devices and medical technologies,...
by IHS | Jul 20, 2021 | Uncategorized
CHESTER, N.Y. (July 20, 2021) – Innovative Health Sciences, LLC (“IHS” or the “Company”) announced today that they have received ISO 13485 quality management system and CE mark certification for the Insignis™ Syringe Infusion System. The CE mark, abbreviated for...
